The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering the Combination Products Summit. The AFDO/RAPS Healthcare Products Collaborative combination products community continues to be led by top FDA officials and worldwide industry leaders who built the framework for the regulatory landscape of combination products. This global community drives innovation and navigates the complexities specific to the world of combination products, resulting in the delivery of safe, effective, and high-quality products to the patients who need them.
Technology
Calendar of Events
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
1 event,
|
1 event,
|
1 event,
|
0 events,
|
1 event,
The Advancing Healthcare Innovation Summit (AHIS2022) is a major healthcare conference and exhibit showcasing the latest innovations related to healthcare and medical sciences. AHIS2022 is a networking conference for all stakeholders in healthcare innovations. |
0 events,
|
0 events,
|
|
0 events,
|
1 event,
The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering Pharmalink in 2022. At PharmaLink, we work to find solutions that will increase confidence in product quality throughout your products’ life cycle management and global supply chain. We do this by aligning with the strategic priorities of the FDA and industry – and by helping participants create network links to drive compliant innovations. The solutions might not be evident within our companies, or our industry, so we explore beyond our industry – beyond borders and beyond comfort zones. |
1 event,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|